Publication | Open Access
Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1
47
Citations
11
References
2010
Year
These findings suggest that the demonstrated benefits of everolimus in the overall trial population are similar in Japanese patients with metastatic renal cell carcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1